Ambev vs Keurig Dr Pepper
ABEV and KDP side by side, both in beverages. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ABEV and KDP compare
Keurig Dr Pepper grew revenue faster over the last twelve months (43.0% versus −1.4% for Ambev).
Ambev keeps more of each dollar of sales as profit, with a net margin of 17.6% compared with 7.1% at Keurig Dr Pepper.
Keurig Dr Pepper pays a dividend yielding 2.4%; Ambev does not pay one.
Ambev scores higher on the StockData Score (12 against 8 for Keurig Dr Pepper), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ABEV | KDP |
|---|---|---|
| Size and price | ||
| Market cap | – | $52.1B |
| Share price | $2.80 | $38.25 |
| Change, 1 year | 14.8% | 46.4% |
| Change, 5 years | −8.5% | 8.8% |
| Beta (5Y) | 0.42 | 0.30 |
| Employees | 40K | 31K |
| StockData Score | ||
| Total score | 12 (better) | 8 |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 | 2 |
| Performance score | 6 (better) | 1 |
| Health score | 4 (better) | 0 |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | – | 35.1× |
| P/S | – | 2.3× |
| P/B | – | 2.0× |
| EV/EBITDA | – | 23.3× |
| P/FCF | – | 22.4× |
| PEG | – | 2.36 |
| FCF yield | – | 4.5% |
| Fair value | – | $28.51 |
| Margin of safety | – | −34.2% |
| Growth | ||
| Revenue growth (TTM) | −1.4% | 43.0% (better) |
| Revenue growth, 5Y average | 8.6% (better) | 7.4% |
| Net income growth (TTM) | 7.4% (better) | 4.1% |
| EPS growth (TTM) | 8.3% (better) | −6.0% |
| EPS growth, 5Y average | 6.6% | 10.5% (better) |
| Profitability | ||
| Gross margin | 51.4% (better) | 48.0% |
| Operating margin | 26.4% (better) | 15.6% |
| Net margin | 17.6% (better) | 7.1% |
| FCF margin | 22.5% (better) | 10.1% |
| Return on equity | 16.6% (better) | 6.5% |
| Return on invested capital | 25.2% (better) | 5.9% |
| Financial health | ||
| Debt / equity | 0.04 (better) | 1.14 |
| Net debt / EBITDA | −0.65 | 7.66 (better) |
| Interest coverage | 5.3× | – |
| Current ratio | 0.96 (better) | 0.52 |
| Altman Z-score | – | 0.96 |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 2.4% |
| Payout ratio | – | 76.0% |
| Years of dividend growth | – | 5 |
| Dividend growth, 5Y average | – | 8.9% |
| Shareholder yield | – | 2.4% |
| Ownership | ||
| Held by institutions | 8.9% | 106% |
| Held by insiders | 0.22% | 4.7% |
| Insider net buying, 12 months | −$2.6M | −$1.1M (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | – | 5.1% |
Go deeper
- ABEV stock overview
- ABEV income statement
- ABEV valuation and score
- KDP stock overview
- KDP income statement
- KDP valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.